MAPT and Alzheimer disease: In recent years, alterations in sleep–wake behavior were proposed to be not only a behavioral symptom of AD pathology but also a facilitator of disease progression, indicating a reciprocal relationship between sleep and early AD biomarkers such as amyloid-beta (Aβ) deposition, tau pathology, circadian Aβ regulation, and glymphatic clearance of Aβ9.